Skip to content Skip to sidebar Skip to footer

Navigating the Threat of Carbapenemase-producing Enterobacterales (CPE): An Exploratory Conversation with Lucas Schulz, PharmD

A surge in Carbapenemase-producing Enterobacterales (CPE) instances, nationwide, is a rising concern for healthcare professionals, particularly due to the prevalence of more difficult-to-treat New Delhi metallo-β-lactamase (NDM) strains. These strains have triggered a shift and challenge in the resistance landscape, having a significant impact on last-line antibiotics. Our conversation with Lucas Schulz, PharmD, medical liaison…

Read more

Battling Antimicrobial Resistance: Diagnostic Stewardship & CPE Incidences

A recent study documented in the American Journal of Infection Control reveals a concerning trend of antibiotic prescribing for Asymptomatic Bacteriuria (ASB) across Department of Veterans Affairs (VA) outpatient clinics, indicating an urgent need for enhanced diagnostic stewardship within healthcare facilities. ASB refers to the occurrence of bacteria in urine devoid of specific urinary tract…

Read more

Rising Tide: Surveillance Data Reveals Increase in Carbapenemase-producing Enterobacterales Infections in Canadian Healthcare Settings

A trend of growing concern amongst Infection Prevention professionals is the rapid spread of Carbapenemase-producing Enterobacterales (CPE) within healthcare facilities. Known for their substantive effect on morbidity and mortality combined with a severely limited treatment scope, these microorganisms have been identified as a significant global health worry. Their easy transmission in healthcare settings has put…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]